Oct 15, 2026 08:46AM
Oct 15, 2026 08:46AM
Sep 16, 2026 07:01AM
Sep 16, 2026 07:00AM
Dec 16, 2024 09:00AM
Nov 7, 2024 09:00AM
Aug 20, 2024 06:41AM H.C. Wainwright Reiterates Neutral Rating on Xenetic Biosciences (XBIO)
Jan 17, 2024 09:04AM
Jan 17, 2024 09:00AM
May 3, 2023 08:35AM
Apr 11, 2023 08:31AM
Apr 11, 2023 08:30AM
Jan 11, 2023 01:00PM
Apr 27, 2022 06:33AM Xenetic Biosciences (XBIO) Expands Oncology Pipeline with In-Licensing of DNase Based Oncology Platform Comprising Multiple Therapeutic Modalities
Apr 27, 2022 06:30AM
Jul 26, 2021 07:02AM
Jul 26, 2021 07:00AM
May 12, 2021 07:00AM
Mar 29, 2021 08:05AM
Mar 17, 2021 08:00AM
Feb 16, 2021 07:30AM Xenetic Biosciences, Inc. Announces Partner's Filing of Registration Dossier in Russia for Epolong Product Candidate That Utilizes Xenetic's PolyXen(R) Platform Technology
Dec 14, 2020 11:15AM
Dec 10, 2020 06:26AM
Dec 10, 2020 12:50AM
Dec 9, 2020 08:38AM
Dec 9, 2020 08:35AM
Nov 13, 2020 08:00AM
Aug 13, 2020 07:05AM Xenetic Biosciences, Inc. Reports Second Quarter 2020 Financial Results and Provides Corporate Update
Jul 30, 2020 08:05AM
Jul 1, 2020 08:09AM
Jul 1, 2020 08:05AM
Jun 16, 2020 08:05AM
May 19, 2020 07:36AM
May 19, 2020 07:35AM
May 14, 2020 04:05PM Xenetic Biosciences, Inc. Reports First Quarter 2020 Financial Results and Provides Corporate Update
Apr 15, 2020 08:35AM
Mar 27, 2020 09:00AM
Feb 27, 2020 08:00AM
Feb 26, 2020 08:00AM
Feb 13, 2020 08:00AM
Feb 11, 2020 08:05AM
Jan 14, 2020 08:42AM Xenetic Biosciences (XBIO) Announces Publication of Data from Partner's Phase 1/2 Study Evaluating Program Leveraging Polyxen Platform Technology
Jan 14, 2020 08:35AM
Nov 15, 2019 08:30AM
Oct 29, 2019 07:05AM
Oct 16, 2019 08:05AM
Oct 8, 2019 08:34AM
Oct 8, 2019 08:30AM
Aug 15, 2019 07:35AM Xenetic Biosciences, Inc. Reports Second Quarter 2019 Financial Results and Provides Corporate Update
Jul 22, 2019 08:00AM

1,201,764 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All